Xcout Intel
Pheon Therapeutics competitors & alternatives
The 12 closest competitors and alternatives to Pheon Therapeutics among biotechnology companies — ranked by similarity to what Pheon Therapeutics actually does, not by market-cap band.
Subscribe to see Pheon Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Pheon Therapeutics
Pheon Therapeutics is a biotechnology research company headquartered in London, England, that specializes in developing next-generation antibody-drug conjugates for hard-to-treat cancers.
Pheon Therapeutics at a glance
Pheon Therapeutics is a biotechnology company headquartered in United Kingdom. It has raised at least $188M across the 2 funding rounds on record. Its most recent funding round, Series B, raised $120M in May 2024. Xcout tracks 8 named people at Pheon Therapeutics, including Cyrus Mozayeni (Chief Executive Officer).
Pheon Therapeutics leadership
- Cyrus MozayeniChief Executive Officer
- Arvin YangChief Medical Officer
- LEIGH ZAWELChief Scientific Officer
- Chung-Han LeeVice President, Clinical Development
- Fu LiVice President and Head of Biology
- Lawrence CripeVice President, Business Development & Corporate Strategy
2 more named people on record for Pheon Therapeutics, with roles, board committees and tenure — see the full roster →
Pheon Therapeutics funding rounds
At least $188M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $120M | 12 named | |
| Series A | $68M | 15 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Pheon Therapeutics competitors
Ranked by semantic similarity — how close each company is to Pheon Therapeutics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Myricx Bio is a UK biotech company headquartered in London. It specializes in the discovery and development of a novel class of selective cytotoxic payloads for Antibody-Drug Conjugates (ADCs).
Similar biotechnology company
PhoreMost Ltd is a Cambridge, United Kingdom-based biotechnology and drug discovery company dedicated to turning scientific breakthroughs into life-changing cancer therapies.
Similar biotechnology company
Alchemab Therapeutics Ltd is a biotechnology company headquartered in London, England, focused on pioneering patient-centric antibody discovery and development.
Biotech
Adcytherix is a clinical-stage biopharmaceutical company that develops next-generation antibody-drug conjugates (ADCs) for oncology. The company combines clinically validated targets with innovative payloads derived from approved cancer drugs to treat resistant cancers and address unmet medical needs.
Similar biotechnology company
NBE-Therapeutics is a biotechnology company founded in 2012 and headquartered in Basel, Switzerland, focused on developing antibody-drug conjugates for oncology treatments.
Similar biotechnology company
Adcendo ApS is a clinical-stage biotechnology company headquartered in Copenhagen, Denmark, with supplementary operations in Boston, Massachusetts. The company specializes in the development of innovative antibody-drug conjugates (ADCs) targeting various oncology indications. Its pipeline focuses on delivering best-in-class clinical treatments for patients with high unmet medical needs.
Life Sciences
Cytospire Therapeutics Limited is a biotechnology research company based in London, United Kingdom. The company is focused on developing a portfolio of next-generation immune cell engagers to improve patients' lives.
Biotech
CrossBridge Bio, Inc. is a medical technology and biopharmaceutical company pioneering an approach to deliver the next generation of stable antibody-drug conjugates (ADCs).
Similar biotechnology company
Valink Therapeutics Inc. is a biotechnology research company headquartered in Cambridge, Massachusetts, with a research and development subsidiary located in London, United Kingdom.
Similar biotechnology company
VelosBio Inc. is a clinical-stage biopharmaceutical company based in California, United States, focused on developing novel antibody-drug conjugates to transform cancer treatment for patients.
Biotech
Philogen is a Swiss-Italian biotechnology company that focuses on the research, development, and commercialization of targeted therapeutics for the treatment of cancer and other serious conditions. The company utilizes proprietary antibody-based technologies to develop biopharmaceuticals, immunotherapies, and radio-conjugates for oncology and imaging applications.
Biotech
AbTx (Antibody for Therapy) is a preclinical-stage biotechnology company headquartered in Dijon, France. The firm designs personalized medicine biotherapies in oncology based on antibody-drug conjugates (ADCs) to treat incurable cancers.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Pheon Therapeutics and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Pheon Therapeuticsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →